Interstitial Lung Disease clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
open to eligible people ages 18 years and up
Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.
Orange, California and other locations
Our lead scientists for Interstitial Lung Disease research studies include Bassam Yaghmour, MD.
Last updated: